Lanreotide

National NHS prescribing (Prescription Cost Analysis) · Sex hormones and hormone antagonists in malignant disease

Data updated March 2026

Lanreotide was ranked 1140th of 1,794 medicines by items in March 2026, with 203 items, down 10.6% on a year earlier.

203items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£169,029

Net ingredient cost · March 2026

NHSBSA PCA

2,594items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Lanreotide: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/lanreotide-0803043p0" width="100%" height="280" style="border:0" loading="lazy" title="Lanreotide: NHS prescribing in England — PharmaInsight"></iframe>

Top presentations, March 2026

The individual products dispensed under Lanreotide, by items this month.

Presentations of Lanreotide, March 2026
Presentation	Items	Net ingredient cost
Lanreotide 120mg/0.5ml inj pre-filled syringes	96	£92,763
Lanreotide 60mg/0.5ml inj pre-filled syringes	55	£33,611
Lanreotide 90mg/0.5ml inj pre-filled syringes	43	£32,384
Somatuline Autogel 120mg/0.5ml inj pfs with safety system	6	£8,433
Somatuline Autogel 60mg/0.5ml inj pfs with safety system	2	£1,102
Somatuline Autogel 90mg/0.5ml inj pfs with safety system	1	£736

Compare Lanreotide with

Other medicines in the same BNF section, by prescribing volume.